Levothyroxine Sodium Injection, Solution
Product Images NDC 63323-885

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 63323-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lev19 0002 01)

FDA Label Image

Fresenius Logo (Lev19 0002 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)
This is a medication called Levothyro, intended for intravenous use without preservatives. It is available in single-dose 5 ml vials, and any unused portion should be discarded. The NOC number is also provided.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)
This is a description of a medication called Levothyroxine Sodium Injection, which comes in a single-dose vial of 5 mL. Each vial contains 100 mcy (micrograms) per 5 mL of medication. This medication is intended for intravenous use and does not contain any preservatives. The manufacturer of this medication is Fresenius Kabi. The instruction advises discarding the unused portion of medication.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)
This is a medication description for Levothyroxine Sodium solution for injection. The National Drug Code (NDC) is 6232389510. The solution has a strength of 500mcg per mL and comes in a 5 mL single-dose vial. It is intended for intravenous use, and has no preservatives. Any unused portion should be discarded.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)
This is a medication called Levothyroxine Sodium Injection that is used for intravenous use. It comes in a 5 mL single-dose vial with a strength of 100 mcg per ml, with a total dosage of 500 mcg per 5 ml. It is preservative-free and any unused portion should be discarded. The manufacturer of the medication is L'H FRESSENS Ratonly KABI.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)
This is a description of a medication called Levothyroxine Sodium. The label indicates that the vial contains 40 mey per L and is intended for intravenous use. The medication does not contain any preservatives and comes in a 5 mL single-dose vial. The label also advises discarding any unused portion.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)
This is a description of Levothyroxine Sodium Injection. It is available in a 5 mL single-dose vial and is intended for intravenous use. The vial contains 200 micrograms of Levothyroxine Sodium, with a TIR-RN value of 40 micrograms. It is preservative-free and any unused portion should be discarded. The manufacturer of the injection is Fresenius Kabi.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.